Opioidergic consequences of dietary-induced binge eating

Physiology and Behavior

Volumn 104, Issue 1, 2011, Pages 98-104

  Bello, Nicholas T ^a   Patinkin, Zachary W ^b   Moran, Timothy H ^b  

^a The State University of New Jersey   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Eating disorders; MOR1; Naloxone; OPRM1

Indexed keywords

FAT; MESSENGER RNA; MU OPIATE RECEPTOR; OPIATE; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINGE EATING DISORDER; BRAIN STEM; CALORIC RESTRICTION; CONTROLLED STUDY; DIET; DIETARY INTAKE; FEMALE; FOREBRAIN; NODOSE GANGLION; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; RHOMBENCEPHALON; RNA ANALYSIS; SOLITARY TRACT NUCLEUS;

ANIMALS; BRAIN STEM; BULIMIA; DIET; EATING; FEEDING BEHAVIOR; FEMALE; NEURAL PATHWAYS; NODOSE GANGLION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; RNA, MESSENGER;

EID: 79957646409     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.04.032     Document Type: Article

References (66)

1. Hsu L.K., Mulliken B., McDonagh B., Krupa Das S., Rand W., Fairburn C.G., et al. Binge eating disorder in extreme obesity. Int J Obes Relat Metab Disord 2002, 26:1398-1403.
2. Elmore D.K., de Castro J.M. Meal patterns of normal, untreated bulimia nervosa and recovered bulimic women. Physiol Behav 1991, 49:99-105.
3. American Psychiatric Association American Psychiatric Association. Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV 1994, American Psychiatric Association, Washington, DC. 4th ed.
4. Mitchell J.E., Pyle R.L., Eckert E., Hatsukami D., Soll E. Bulimia nervosa with and without a history of overweight. J Subst Abuse 1990, 2:369-374.
5. Chen Y., Bidwell L.C., Norton D. Trait vs. state markers for schizophrenia: identification and characterization through visual processes. Curr Psychiatry Rev 2006, 2:431-438.
6. Gottesman I.I., Shields J. Genetic theorizing and schizophrenia. Br J Psychiatry 1973, 122:15-30.
7. Kinzig K.P., Hargrave S.L., Honors M.A. Binge-type eating attenuates corticosterone and hypophagic responses to restraint stress. Physiol Behav 2008, 95:108-113.
8. Hagan M.M., Wauford P.K., Chandler P.C., Jarrett L.A., Rybak R.J., Blackburn K. A new animal model of binge eating: key synergistic role of past caloric restriction and stress. Physiol Behav 2002, 77:45-54.
9. Corwin R.L., Wojnicki F.H., Fisher J.O., Dimitriou S.G., Rice H.B., Young M.A. Limited access to a dietary fat option affects ingestive behavior but not body composition in male rats. Physiol Behav 1998, 65:545-553.
10. Colantuoni C., Schwenker J., McCarthy J., Rada P., Ladenheim B., Cadet J.L., et al. Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport 2001, 12:3549-3552.
11. Colantuoni C., Rada P., McCarthy J., Patten C., Avena N.M., Chadeayne A., et al. Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence. Obes Res 2002, 10:478-488.
12. Avena N.M., Rada P., Hoebel B.G. Sugar bingeing in rats. Curr Protoc Neurosci 2006, Chapter 9(Unit9):23C.
13. Avena N.M., Rada P., Hoebel B.G. Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev 2008, 32:20-39.
14. Yeomans M.R., Gray R.W. Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev 2002, 26:713-728.
15. Drewnowski A., Krahn D.D., Demitrack M.A., Nairn K., Gosnell B.A. Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters. Am J Clin Nutr 1995, 61:1206-1212.
16. Fantino M., Hosotte J., Apfelbaum M. An opioid antagonist, naltrexone, reduces preference for sucrose in humans. Am J Physiol 1986, 251:R91-R96.
17. Jonas J.M., Gold M.S. The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone. Psychiatry Res 1988, 24:195-199.
18. Chatoor I., Herman B.H., Hartzler J. Effects of the opiate antagonist, naltrexone, on binging antecedents and plasma beta-endorphin concentrations. J Am Acad Child Adolesc Psychiatry 1994, 33:748-752.
19. Marrazzi M.A., Bacon J.P., Kinzie J., Luby E.D. Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa. Int Clin Psychopharmacol 1995, 10:163-172.
20. Marrazzi M.A., Wroblewski J.M., Kinzie J., Luby E.D. High-dose naltrexone and liver function safety. Am J Addict 1997, 6:21-29.
21. Bencherif B., Guarda A.S., Colantuoni C., Ravert H.T., Dannals R.F., Frost J.J. Regional mu-opioid receptor binding in insular cortex is decreased in bulimia nervosa and correlates inversely with fasting behavior. J Nucl Med 2005, 46:1349-1351.
22. Waller D.A., Kiser R.S., Hardy B.W., Fuchs I., Feigenbaum L.P., Uauy R. Eating behavior and plasma beta-endorphin in bulimia. Am J Clin Nutr 1986, 44:20-23.
23. Kales E.F. Macronutrient analysis of binge eating in bulimia. Physiol Behav 1990, 48:837-840.
24. Drewnowski A., Bellisle F., Aimez P., Remy B. Taste and bulimia. Physiol Behav 1987, 41:621-626.
25. Raymond N.C., Neumeyer B., Warren C.S., Lee S.S., Peterson C.B. Energy intake patterns in obese women with binge eating disorder. Obes Res 2003, 11:869-879.
26. Avena N.M. Examining the addictive-like properties of binge eating using an animal model of sugar dependence. Exp Clin Psychopharmacol 2007, 15:481-491.
27. Spangler R., Wittkowski K.M., Goddard N.L., Avena N.M., Hoebel B.G., Leibowitz S.F. Opiate-like effects of sugar on gene expression in reward areas of the rat brain. Brain Res Mol Brain Res 2004, 124:134-142.
28. Carr K.D., Kutchukhidze N. Chronic food restriction increases fos-like immunoreactivity (FLI) induced in rat forebrain by intraventricular amphetamine. Brain Res 2000, 861:88-96.
29. Kim E.M., Shi Q., Olszewski P.K., Grace M.K., O'Hare E., Billington C.J., et al. Identification of central sites involved in butorphanol-induced feeding in rats. Brain Res 2001, 907:125-129.
30. Ward H.G., Nicklous D.M., Aloyo V.J., Simansky K.J. Mu-opioid receptor cellular function in the nucleus accumbens is essential for hedonically driven eating. Eur J Neurosci 2006, 23:1605-1613.
31. Ward H.G., Simansky K.J. Chronic prevention of mu-opioid receptor (MOR) G-protein coupling in the pontine parabrachial nucleus persistently decreases consumption of standard but not palatable food. Psychopharmacology 2006, 187:435-446. (Berl).
32. Wilson J.D., Nicklous D.M., Aloyo V.J., Simansky K.J. An orexigenic role for mu-opioid receptors in the lateral parabrachial nucleus. Am J Physiol Regul Integr Comp Physiol 2003, 285:R1055-R1065.
33. Schwartz G.J. Integrative capacity of the caudal brainstem in the control of food intake. Philos Trans R Soc Lond B Biol Sci 2006, 361:1275-1280.
34. Grill H.J., Hayes M.R. The nucleus tractus solitarius: a portal for visceral afferent signal processing, energy status assessment and integration of their combined effects on food intake. Int J Obes (Lond) 2009, 33(Suppl. 1):S11-S15.
35. Faulconbridge L.F., Cummings D.E., Kaplan J.M., Grill H.J. Hyperphagic effects of brainstem ghrelin administration. Diabetes 2003, 52:2260-2265.
36. Grill H.J., Schwartz M.W., Kaplan J.M., Foxhall J.S., Breininger J., Baskin D.G. Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology 2002, 143:239-246.
37. Hayes, M. R., Leichner, T. M., Zhao, S., Lee, G. S., Chowansky, A., Zimmer, D., et al. Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation. Cell Metab.13:320-30.
38. Hayes, M. R., De Jonghe, B. C., Kanoski, S. E. Role of the glucagon-like-peptide-1 receptor in the control of energy balance. Physiol Behav.100:503-10.
39. Hayes M.R., Bradley L., Grill H.J. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling. Endocrinology 2009, 150:2654-2659.
40. Emond M., Ladenheim E.E., Schwartz G.J., Moran T.H. Leptin amplifies the feeding inhibition and neural activation arising from a gastric nutrient preload. Physiol Behav 2001, 72:123-128.
41. Hellstrom P.M., Geliebter A., Naslund E., Schmidt P.T., Yahav E.K., Hashim S.A., et al. Peripheral and central signals in the control of eating in normal, obese and binge-eating human subjects. Br J Nutr 2004, 92(Suppl. 1):S47-S57.
42. Geliebter A., Yahav E.K., Gluck M.E., Hashim S.A. Gastric capacity, test meal intake, and appetitive hormones in binge eating disorder. Physiol Behav 2004, 81:735-740.
43. Geliebter A., Hashim S.A. Gastric capacity in normal, obese, and bulimic women. Physiol Behav 2001, 74:743-746.
44. Ding Y.Q., Kaneko T., Nomura S., Mizuno N. Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat. J Comp Neurol 1996, 367:375-402.
45. Nomura S., Ding Y.Q., Kaneko T., Li J.L., Mizuno N. Localization of mu-opioid receptor-like immunoreactivity in the central components of the vagus nerve: a light and electron microscope study in the rat. Neuroscience 1996, 73:277-286.
46. Mansour A., Fox C.A., Thompson R.C., Akil H., Watson S.J. mu-Opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding. Brain Res 1994, 643:245-265.
47. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., et al. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 1994, 350:412-438.
48. Aicher S.A., Goldberg A., Sharma S., Pickel V.M. mu-Opioid receptors are present in vagal afferents and their dendritic targets in the medial nucleus tractus solitarius. J Comp Neurol 2000, 422:181-190.
49. Glass M.J., Briggs J.E., Billington C.J., Kotz C.M., Levine A.S. Opioid receptor blockade in rat nucleus tractus solitarius alters amygdala dynorphin gene expression. Am J Physiol Regul Integr Comp Physiol 2002, 283:R161-R167.
50. Kotz C.M., Glass M.J., Levine A.S., Billington C.J. Regional effect of naltrexone in the nucleus of the solitary tract in blockade of NPY-induced feeding. Am J Physiol Regul Integr Comp Physiol 2000, 278:R499-R503.
51. Bello N.T., Guarda A.S., Terrillion C.E., Redgrave G.W., Coughlin J.W., Moran T.H. Repeated binge access to a palatable food alters feeding behavior, hormone profile, and hindbrain c-Fos responses to a test meal in adult male rats. Am J Physiol Regul Integr Comp Physiol 2009, 297:R622-R631.
52. Goldman J.M., Murr A.S., Cooper R.L. The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol 2007, 80:84-97.
53. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego. 4th ed.
54. McGee, H. M., Amare, B., Bennett, A. L., Duncan-Vaidya, E. A. Behavioral effects of withdrawal from sweetened vegetable shortening in rats. Brain Res.1350:103-11.
55. Dimitriou S.G., Rice H.B., Corwin R.L. Effects of limited access to a fat option on food intake and body composition in female rats. Int J Eat Disord 2000, 28:436-445.
56. Berner L.A., Avena N.M., Hoebel B.G. Bingeing, self-restriction, and increased body weight in rats with limited access to a sweet-fat diet. Obesity 2008, 16:1998-2002. (Silver Spring).
57. Cottone P., Sabino V., Steardo L., Zorrilla E.P. Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food. Neuropsychopharmacology 2008, 33:524-535.
58. Blundell J.E., Lawton C.L., Cotton J.R., Macdiarmid J.I. Control of human appetite: implications for the intake of dietary fat. Annu Rev Nutr 1996, 16:285-319.
59. Levine A.S., Billington C.J. Opioids as agents of reward-related feeding: a consideration of the evidence. Physiol Behav 2004, 82:57-61.
60. Kotz C.M., Billington C.J., Levine A.S. Opioids in the nucleus of the solitary tract are involved in feeding in the rat. Am J Physiol 1997, 272:R1028-R1032.
61. Kotz C.M., Grace M.K., Briggs J., Levine A.S., Billington C.J. Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action. J Clin Invest 1995, 96:163-170.
62. Travagli R.A., Hermann G.E., Browning K.N., Rogers R.C. Brainstem circuits regulating gastric function. Annu Rev Physiol 2006, 68:279-305.
63. Browning K.N., Travagli R.A. Short-term receptor trafficking in the dorsal vagal complex: an overview. Auton Neurosci 2006, 126-127:2-8.
64. Browning K.N., Kalyuzhny A.E., Travagli R.A. Opioid peptides inhibit excitatory but not inhibitory synaptic transmission in the rat dorsal motor nucleus of the vagus. J Neurosci 2002, 22:2998-3004.
65. Herman, M. A., Alayan, A., Sahibzada, N., Bayer, B., Verbalis, J., Dretchen, K. L., et al. micro-Opioid receptor stimulation in the medial subnucleus of the tractus solitarius inhibits gastric tone and motility by reducing local GABA activity. Am J Physiol Gastrointest Liver Physiol.299:G494-506.
66. Avena N.M., Rada P., Hoebel B.G. Sugar and fat bingeing have notable differences in addictive-like behavior. J Nutr 2009, 139:623-628.